202 related articles for article (PubMed ID: 16234821)
1. The clinical potential of antiangiogenic fragments of extracellular matrix proteins.
Clamp AR; Jayson GC
Br J Cancer; 2005 Oct; 93(9):967-72. PubMed ID: 16234821
[TBL] [Abstract][Full Text] [Related]
2. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin.
Folkman J
Sci STKE; 2006 Sep; 2006(354):pe35. PubMed ID: 17003465
[TBL] [Abstract][Full Text] [Related]
4. Endostatin signaling and regulation of endothelial cell-matrix interactions.
Wickström SA; Alitalo K; Keski-Oja J
Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
[TBL] [Abstract][Full Text] [Related]
5. Collagen XVIII/endostatin structure and functional role in angiogenesis.
Zatterstrom UK; Felbor U; Fukai N; Olsen BR
Cell Struct Funct; 2000 Apr; 25(2):97-101. PubMed ID: 10885579
[TBL] [Abstract][Full Text] [Related]
6. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases.
Heljasvaara R; Nyberg P; Luostarinen J; Parikka M; Heikkilä P; Rehn M; Sorsa T; Salo T; Pihlajaniemi T
Exp Cell Res; 2005 Jul; 307(2):292-304. PubMed ID: 15950618
[TBL] [Abstract][Full Text] [Related]
7. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord injury-induced expression of the antiangiogenic endostatin/collagen XVIII in areas of vascular remodelling.
Mueller CA; Conrad S; Schluesener HJ; Pietsch T; Schwab JM
J Neurosurg Spine; 2007 Aug; 7(2):205-14. PubMed ID: 17688061
[TBL] [Abstract][Full Text] [Related]
9. Endostatin's endpoints-Deciphering the endostatin antiangiogenic pathway.
Benezra R; Rafii S
Cancer Cell; 2004 Mar; 5(3):205-6. PubMed ID: 15050911
[TBL] [Abstract][Full Text] [Related]
10. Non-heparan sulfate-binding interactions of endostatin/collagen XVIII in murine development.
Rychkova N; Stahl S; Gaetzner S; Felbor U
Dev Dyn; 2005 Feb; 232(2):399-407. PubMed ID: 15614762
[TBL] [Abstract][Full Text] [Related]
11. [Pathophysiological role of endostatin in non-malignant disorders].
Kucharz EJ; Kotulska A
Pol Arch Med Wewn; 2006 Jun; 115(6):507-11. PubMed ID: 17263221
[No Abstract] [Full Text] [Related]
12. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity.
Sasaki T; Larsson H; Tisi D; Claesson-Welsh L; Hohenester E; Timpl R
J Mol Biol; 2000 Sep; 301(5):1179-90. PubMed ID: 10966814
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events.
Sánchez-Arévalo Lobo VJ; Cuesta AM; Sanz L; Compte M; García P; Prieto J; Blanco FJ; Alvarez-Vallina L
Int J Cancer; 2006 Jul; 119(2):455-62. PubMed ID: 16477626
[TBL] [Abstract][Full Text] [Related]
14. Altered angiogenic balance in keloids: a key to therapeutic intervention.
Mogili NS; Krishnaswamy VR; Jayaraman M; Rajaram R; Venkatraman A; Korrapati PS
Transl Res; 2012 Mar; 159(3):182-9. PubMed ID: 22340768
[TBL] [Abstract][Full Text] [Related]
15. Endostatin affects osteoblast behavior in vitro, but collagen XVIII/endostatin is not essential for skeletal development in vivo.
Sipola A; Seppinen L; Pihlajaniemi T; Tuukkanen J
Calcif Tissue Int; 2009 Nov; 85(5):412-20. PubMed ID: 19763371
[TBL] [Abstract][Full Text] [Related]
16. Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model.
Maciel TT; Coutinho EL; Soares D; Achar E; Schor N; Bellini MH
J Nephrol; 2008; 21(5):753-60. PubMed ID: 18949731
[TBL] [Abstract][Full Text] [Related]
17. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
[TBL] [Abstract][Full Text] [Related]
18. Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.
Tanabe K; Maeshima Y; Ichinose K; Kitayama H; Takazawa Y; Hirokoshi K; Kinomura M; Sugiyama H; Makino H
Kidney Int; 2007 Feb; 71(3):227-38. PubMed ID: 17191085
[TBL] [Abstract][Full Text] [Related]
19. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
[TBL] [Abstract][Full Text] [Related]
20. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
